Science Writers Learn About Translational Research
On February 14, 20 science reporters and other media representatives came to the Moores UCSD Cancer Center on the campus of the University of California, San Diego (UCSD) in La Jolla for the most recent in NCI's continuing series of seminars, "The Basics of Clinical Advances," which featured an update on NCI's translational research initiatives. Representatives from the San Diego Union-Tribune and other major local papers heard presentations from cancer researchers from NCI, UCSD, the Burnham Institute for Medical Research, and the Salk Institute for Biological Studies.

NCI's Dr. Jerry Collins discussed "NCI's role in turning discoveries into medicines"; Dr. Reuben Shaw of the Salk Institute described "How decoding circuitry underlying tumor development may lead to targeted cancer therapies"; Dr. Dwayne Stupack of UCSD spoke on "New opportunities to control tumor spread"; and Dr. Kristiina Vuori of the Burnham Institute discussed "From breakthroughs in the laboratory to the discovery of new drugs: San Diego Center for Chemical Genomics."

WHI Meeting to Discuss Study Results
On February 28-March 1, "The Women's Health Initiative Legacy to Future Generations of Women: Update on Scientific Contributions" will take place in the Natcher Auditorium on the NIH campus in Bethesda, Md. Representatives from the Women's Health Initiative (WHI) and other scientific organizations will discuss the recently released results from this randomized trial, which includes more than 161,000 women in all parts of the country. More information is available online at http://www.nhlbi.nih.gov/whi/references.htm.

Save the Date for Advocacy Conference
On June 19-20, NCI's Office of Liaison Activities will host "Listening and Learning Together: Building a Bridge of Trust," a meeting for the cancer advocacy community. The goal of the meeting is to bring together cancer advocacy organizations to develop ways to improve communication between and among NCI and advocates. The meeting will take place in the Natcher Conference Center on the NIH campus in Bethesda, Md. The event is free, but participants must register in advance; there will be no onsite registration. More information is available online at http://www.palladianpartners.com/NCISummit2006/index.htm.

Clinical Proteomics Meeting
A pre-application meeting for the Clinical Proteomic Technology Assessment for Cancer RFA will take place on Feb. 27 in the Natcher Conference Center at NIH. The meeting will outline the initiative and answer questions about the RFA (http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3342).

The meeting is free, but registration is required. To register, go to http://proteomics.cancer.gov. The meeting will be webcast at http://videocast.nih.gov. Inquiries: Dr. Adam Michael Clark - clarkad@mail.nih.gov. For the latest news from the NCI Clinical Proteomic Technologies Initiative for Cancer, sign up at http://proteomics.cancer.gov/email_signup.asp.